Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating
MT NewswiresNov 14, 2022 08:52 ET
Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating
MT NewswiresSep 27, 2022 08:48 ET
Brickell Biotech Price Target Raised to $4.50/Share From $2.00 by HC Wainwright & Co.
Dow JonesAug 16, 2022 06:46 ET
Brickell Biotech Is Maintained at Buy by HC Wainwright & Co.
Dow JonesAug 16, 2022 06:46 ET
Analysts Offer Insights on Healthcare Companies: Brickell Biotech (BBI), Phio Pharmaceuticals (PHIO) and Albireo Pharma (ALBO)
TipRanksAug 16, 2022 06:45 ET
Brickell Biotech Analyst Ratings
Benzinga Analyst RatingsAug 16, 2022 06:36 ET
No Data
No Data